Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Por um escritor misterioso
Descrição
IJMS, Free Full-Text
IJMS, Free Full-Text
ASAS20/40 response rates and mean change from baseline in BASDAI
Effects of ustekinumab on spondylitis-associated endpoints in TNFi
Changes in disease activity after 12 weeks of anti-TNF-α therapy
Disease activity over time in AS patients. ASDAS over time in
Physical Function and Spinal Mobility Remain Stable Despite
TNF Inhibitor Therapy, Ankylosing Spondylitis
Measures of symptoms and disease status in ankylosing spondylitis
de
por adulto (o preço varia de acordo com o tamanho do grupo)